Navigation Links
USDA Boosts Food Safety Research with Purchase of Waters ACQUITY TQD System
Date:2/27/2009

UPLC/Tandem Quadrupole Mass Spectrometry System Intended for Veterinary Drug Residue Analysis of Poultry and Livestock

MILFORD, Mass., Feb. 27 /PRNewswire-FirstCall/ -- Waters Corporation (NYSE: WAT) announced today that the United States Department of Agriculture's Agricultural Research Service has purchased a Waters(R) ACQUITY(R) TQD System to develop rapid and accurate test methods for screening poultry and beef for trace concentrations of veterinary drug residues. The instrument purchased is for the USDA's Wyndmoor, Pa. research laboratory.

Farm-raised poultry and livestock often receive drugs to protect them from disease and promote their growth. Through ignorance, carelessness or deceit on the part of a small number of producers, poultry and livestock that enter the food chain can contain banned substances or legal drugs at concentrations that exceed maximum allowable levels. The need to obtain more information from a single injection is underscored by increasing demands on laboratory time and resources for reproducible, highly-accurate and precise results on larger numbers of samples.

Analytical methods that employ UltraPerformance Liquid Chromatography (UPLC(R)) coupled with tandem mass spectrometry can screen for more than 100 different drug residues at a time at concentrations of less than 10 ng/mL, a big improvement in speed, efficiency, and sensitivity over the traditional seven-plate bioassay method.

The USDA chose Waters ACQUITY TQD System based on criteria for a UPLC/MS/MS system with a tandem quadrupole mass spectrometry detector capable of 20 millisecond positive and negative switching, a feature deemed highly-important for multi-analyte detection of both positively and negatively-charged compounds in a single analytical run.

Waters ACQUITY TQD System features the Waters ACQUITY UltraPerformance LC(R) System (UPLC(R)), a tandem quadrupole (TQ) mass detector, ACQUITY BEH analytical columns, all operated under Waters MassLynx(TM) 4.1 Mass Spectrometry Software. The MassLynx Software includes TargetLynx(TM) software for targeted analyte quantification and the QuanOptimise(TM) feature for automated system optimization and method development. This UPLC/MS/MS system operates with 1.7 micron ACQUITY BEH Columns and is a true UPLC system for measuring concentrations of veterinary drug residues, pesticides, and other contaminants in foods and beverages.

For More Information

More information on Waters ACQUITY TQD System, visit www.waters.com/tqd. For more information on Waters entire portfolio of LC/MS/MS products, please visit: http://www.waters.com/ms.

About Waters Corporation

Waters Corporation creates business advantages for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide.

Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success.

With revenue of $1.58 billion in 2008 and 5,000 employees, Waters is driving scientific discovery and operational excellence for customers worldwide.

Waters, UltraPerformance LC, UPLC, ACQUITY, MassLynx, QuanOptimise, and TargetLynx are trademarks of Waters Corporation.

    Contact:
    Brian J. Murphy
    Waters Corporation
    Public Relations Manager
    508-482-2614
    Brian_J_Murphy@waters.com


'/>"/>
SOURCE Waters Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. KanekaQH(TM) Ubiquinol Dramatically Boosts Ejection Fraction in Patients With Late-Stage Congestive Heart Failure
2. Winning University of Melbourne Ph.D. research boosts the search for sensitive sensors
3. New Study Finds Growth Factor Boosts Productivity in Mammalian Cell Culture
4. On the boil: New nano technique significantly boosts boiling efficiency
5. Genzyme Boosts Quality Using Dyadem Quality Lifecycle Management
6. Cystic Fibrosis: License Agreement Boosts Development of Therapy Against Lung Infections
7. New Scandinavian collaboration boosts nanotech development
8. Murad Boosts Skin Immunity With the New Murad(R) Professional Line
9. Hospira Advances Patient Safety With New GemStar(R) SP Infusion System
10. Poniard Pharmaceuticals Announces New Efficacy and Safety Data from a Phase 2 Picoplatin Trial in Patients with Prostate Cancer
11. Orcrist Bio Inc. Files with European Competent Authority for a Phase I, Open-label, Single-ascending-dose, Safety Study of HYC750
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... January 20, 2017 http://www.Financialbuzz.com ... one of leading causes of death worldwide. There were ... number of cancer related deaths increased gradually over time, ... incidence rate of various cancers continues to drive demand ... report by Global Market Insights, Inc. cancer biological therapy ...
(Date:1/19/2017)... SHANGHAI , Jan. 19, 2017 /PRNewswire -- ... medical device open-access capability and technology platform, today ... a leading biology focused preclinical drug discovery contract ... Biosciences will become a wholly-owned subsidiary of WuXi, ... core competences and providing greater services. The acquisition ...
(Date:1/19/2017)... 2017  ArmaGen, Inc., today announced that it ... chief executive officer, as well as a member ... ArmaGen more than 17 years of executive management ... biotherapeutics and pharmaceuticals. "Mathias is ... and skillset necessary to lead ArmaGen to its ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... services spanning the full spectrum of drug and device development, and Prism ... pharma/device companies and clinicians, today announced Verified Clinical Trials (VCT) has ...
Breaking Biology Technology:
(Date:1/4/2017)... VEGAS , Jan. 4, 2017  CES ... performance biometric sensor technology, today announced the launch ... sensor systems, the highly-accurate biometric sensor modules ... biometric technology, experience and expertise. The two ... Benchmark designed specifically for hearables, and Benchmark BW2.0, ...
(Date:12/22/2016)... YORK , December 22, 2016 ... provider of secure solutions for the e-Government, Public Safety, HealthCare, and ... subsidiary of SuperCom, has been selected to implement and deploy a ... in Northern California , further expanding its presence ... ...
(Date:12/19/2016)... 19 de diciembre de 2016  Mosaic Biomedicals SL anunció hoy ... de MSC-1, un anticuerpo humanizado que se espera comenzar a utilizar ... múltiples sitios previstos a lo largo de Europa y Norteamérica. ... MSC-1 es el primer ... leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa en ciertos tumores ...
Breaking Biology News(10 mins):